-
公开(公告)号:JP2008115189A
公开(公告)日:2008-05-22
申请号:JP2007327351
申请日:2007-12-19
Applicant: Abbott Lab , アボット・ラボラトリーズAbbott Laboratories
Inventor: SHAM HING LEUNG , NORBECK DANIEL W , CHEN XIAOQI , BETEBENNER DAVID A , DALE J KEMP , THOMAS R HERIN , GONDEI N KUMAA , STEVEN L CONDON , ARTHUR J COOPER , DANIEL A DICKMAN , STEVEN M HANNIKKU , LAWRENCE KORATSUEKOUSUKII , PATRICIA A OLIVER , DANIEL J PRATA , PETER J STENGEL , ERIK J SUTOONAA , JII-HAA J TEIEN , JII-HOWA RIU , KETAN M PATEL
IPC: C07D207/27 , C07D253/00 , A61K31/00 , A61K31/40 , A61K31/4015 , A61K31/41 , A61K31/415 , A61K31/4164 , A61K31/4166 , A61K31/4178 , A61K31/4184 , A61K31/42 , A61K31/421 , A61K31/425 , A61K31/427 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/4439 , A61K31/47 , A61K31/495 , A61K31/496 , A61K31/4965 , A61K31/505 , A61K31/506 , A61K31/513 , A61K31/53 , A61K31/55 , A61K38/05 , A61K45/00 , A61P31/18 , A61P43/00 , C07C231/12 , C07C235/20 , C07C273/18 , C07C275/16 , C07D20060101 , C07D207/22 , C07D207/26 , C07D207/273 , C07D207/34 , C07D207/40 , C07D207/404 , C07D207/408 , C07D207/416 , C07D211/72 , C07D211/84 , C07D223/06 , C07D233/28 , C07D233/30 , C07D233/32 , C07D233/34 , C07D233/36 , C07D233/40 , C07D233/42 , C07D233/66 , C07D239/06 , C07D239/10 , C07D239/20 , C07D239/22 , C07D241/06 , C07D241/08 , C07D241/18 , C07D243/04 , C07D253/06 , C07D263/16 , C07D263/20 , C07D263/22 , C07D263/34 , C07D265/04 , C07D267/04 , C07D277/12 , C07D277/32 , C07D277/34 , C07D279/06 , C07D281/02 , C07D401/12 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/12
CPC classification number: C07D207/27 , C07D207/404 , C07D207/408 , C07D223/10 , C07D233/32 , C07D233/42 , C07D239/10 , C07D239/22 , C07D241/08 , C07D241/18 , C07D253/06 , C07D263/22 , C07D307/20 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D409/14 , C07D417/12
Abstract: PROBLEM TO BE SOLVED: To provide a new compound as an HIV protease inhibiting compound, and to provide a production intermediate thereof. SOLUTION: A compound represented by formula (1) is provided. Wherein, R1 and R2 are independently selected from the group consisting of an alkyl, a cycloalkyl and an arylalkyl; R3 is a lower alkyl, a hydroxyalkyl, or a cycloalkylalkyl; R4 is an aryl or a heterocycle; R5 is a 5-7 membered ring containing nitrogen atom and having a hetero atom directly bonded with the heterocycle; and L1 is a bivalent bonding group such as -O- or -S-. COPYRIGHT: (C)2008,JPO&INPIT
Abstract translation: 待解决的问题:提供新的化合物作为HIV蛋白酶抑制化合物,并提供其生产中间体。 解决方案:提供由式(1)表示的化合物。 其中R1和R2独立地选自烷基,环烷基和芳基烷基; R3是低级烷基,羟基烷基或环烷基烷基; R4是芳基或杂环; R5是含有氮原子的5-7元环,并且具有与杂环直接键合的杂原子; 并且L1是二价键合基团,例如-O-或-S-。 版权所有(C)2008,JPO&INPIT
-
公开(公告)号:JP2006232845A
公开(公告)日:2006-09-07
申请号:JP2006103462
申请日:2006-04-04
Applicant: Abbott Lab , アボツト・ラボラトリーズ
Inventor: KEMPF DALE J , NORBECK DANIEL W , SHAM HING L , CHEN ZUAO , THOMAS J SOOUIN , DANIEL S RENO , HAIGHT ANTHONY R , ARTHUR J COOPER
IPC: C07D263/32 , C07D275/02 , A61K31/395 , A61K31/415 , A61K31/4164 , A61K31/42 , A61K31/421 , A61K31/422 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/535 , A61K31/5375 , A61K31/5377 , A61K31/54 , A61K38/00 , A61K45/06 , A61P31/12 , A61P31/18 , A61P35/00 , A61P35/02 , A61P37/04 , A61P43/00 , C07C33/46 , C07C43/164 , C07C43/174 , C07C43/205 , C07C43/215 , C07C43/23 , C07C43/30 , C07C43/315 , C07C45/00 , C07C45/29 , C07C45/56 , C07C45/62 , C07C45/67 , C07C45/74 , C07C53/134 , C07C69/34 , C07C69/65 , C07C69/732 , C07C211/27 , C07C215/18 , C07C215/20 , C07C215/28 , C07C229/08 , C07C229/26 , C07C229/34 , C07C233/36 , C07C233/40 , C07C235/10 , C07C235/12 , C07C235/34 , C07C235/78 , C07C237/10 , C07C237/20 , C07C237/22 , C07C239/10 , C07C239/18 , C07C239/20 , C07C247/10 , C07C251/40 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/16 , C07C275/24 , C07C311/03 , C07C311/13 , C07C311/18 , C07C317/10 , C07C317/28 , C07C317/44 , C07C323/12 , C07C323/25 , C07C381/00 , C07D20060101 , C07D213/26 , C07D213/30 , C07D213/34 , C07D213/40 , C07D213/54 , C07D213/56 , C07D213/61 , C07D213/75 , C07D233/54 , C07D233/84 , C07D235/10 , C07D235/14 , C07D235/16 , C07D239/26 , C07D241/12 , C07D261/06 , C07D261/08 , C07D263/24 , C07D263/30 , C07D263/48 , C07D265/30 , C07D277/20 , C07D277/22 , C07D277/24 , C07D277/26 , C07D277/28 , C07D277/30 , C07D277/32 , C07D277/34 , C07D277/36 , C07D277/40 , C07D277/42 , C07D277/56 , C07D295/13 , C07D295/205 , C07D295/215 , C07D303/36 , C07D307/42 , C07D333/16 , C07D401/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D521/00 , C07F5/02 , C07F5/04 , C07K5/06 , C07K5/065
CPC classification number: C07D413/12 , A61K31/425 , A61K31/427 , A61K31/70 , A61K38/00 , A61K45/06 , C07C33/46 , C07C43/164 , C07C43/1742 , C07C43/2055 , C07C43/215 , C07C43/23 , C07C43/30 , C07C43/315 , C07C45/004 , C07C45/29 , C07C45/567 , C07C45/62 , C07C45/673 , C07C45/74 , C07C53/134 , C07C69/34 , C07C69/65 , C07C69/732 , C07C211/27 , C07C215/18 , C07C215/20 , C07C215/28 , C07C229/08 , C07C229/26 , C07C229/34 , C07C233/36 , C07C233/40 , C07C235/10 , C07C235/12 , C07C235/34 , C07C235/78 , C07C237/10 , C07C237/20 , C07C237/22 , C07C239/10 , C07C239/18 , C07C239/20 , C07C247/10 , C07C251/40 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/16 , C07C275/24 , C07C311/03 , C07C311/13 , C07C311/18 , C07C317/10 , C07C317/28 , C07C317/44 , C07C323/12 , C07C323/25 , C07C381/00 , C07D213/26 , C07D213/30 , C07D213/34 , C07D213/40 , C07D213/54 , C07D213/56 , C07D213/61 , C07D213/75 , C07D231/12 , C07D233/56 , C07D233/64 , C07D233/84 , C07D235/14 , C07D235/16 , C07D239/26 , C07D241/12 , C07D249/08 , C07D261/08 , C07D263/32 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/34 , C07D277/36 , C07D277/40 , C07D277/42 , C07D277/56 , C07D295/13 , C07D295/205 , C07D295/215 , C07D303/36 , C07D307/42 , C07D333/16 , C07D401/12 , C07D417/12 , C07K5/06026 , C07K5/06078 , A61K31/00 , A61K2300/00 , C07C49/233 , C07C49/255 , C07C49/215 , C07C49/245 , C07C49/235 , C07C49/223
Abstract: PROBLEM TO BE SOLVED: To provide an HIV protease inhibitor useful for treating or preventing AIDS. SOLUTION: The retroviral protease-inhibiting compound is represented by general formula (A). Preferably, in the formula, R 1 is a thiazolyl or oxazolyl which may be substituted; n is 1; R 2 is hydrogen; R 3 is a 1-4C alkyl; R 4 and R 4a are each phenyl; R 6 is hydrogen; R 7 is thiazolyl, oxazolyl or the like; and Z is O. COPYRIGHT: (C)2006,JPO&NCIPI
Abstract translation: 待解决的问题:提供可用于治疗或预防艾滋病的HIV蛋白酶抑制剂。 解决方案:逆转录病毒蛋白酶抑制化合物由通式(A)表示。 优选地,在该式中,R SB 1是可被取代的噻唑基或恶唑基; n为1; R SB 2是氢; R SB 3是一个1-4C烷基; R SB 4和R SB 4各自为苯基; R SB 6是氢; R 7是噻唑基,恶唑基等; Z为O.版权所有(C)2006,JPO&NCIPI
-
公开(公告)号:JP2013047266A
公开(公告)日:2013-03-07
申请号:JP2012245536
申请日:2012-11-07
Applicant: Abbott Lab , アボット・ラボラトリーズAbbott Laboratories
Inventor: SHAM HING LEUNG , NORBECK DANIEL W , CHEN XIAOQI , BETEBENNER DAVID A , DALE J KEMP , THOMAS R HERIN , GONDEI N KUMAA , STEVEN L CONDON , ARTHUR J COOPER , DANIEL A DICKMAN , STEVEN M HANNIKKU , LAWRENCE KORATSUEKOUSUKII , PATRICIA A OLIVER , DANIEL J PRATA , PETER J STENGEL , ERIK J SUTOONAA , JII-HAA J TEIEN , JII-HOWA RIU , KETAN M PATEL
IPC: C07D207/26 , C07D253/00 , A61K31/00 , A61K31/40 , A61K31/4015 , A61K31/41 , A61K31/415 , A61K31/4164 , A61K31/4166 , A61K31/4178 , A61K31/4184 , A61K31/42 , A61K31/421 , A61K31/425 , A61K31/427 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/4439 , A61K31/47 , A61K31/495 , A61K31/496 , A61K31/4965 , A61K31/505 , A61K31/506 , A61K31/513 , A61K31/53 , A61K31/55 , A61K38/05 , A61K45/00 , A61P31/18 , A61P43/00 , C07C231/12 , C07C235/20 , C07C273/18 , C07C275/16 , C07D20060101 , C07D201/08 , C07D207/22 , C07D207/27 , C07D207/273 , C07D207/34 , C07D207/40 , C07D207/404 , C07D207/408 , C07D207/416 , C07D211/72 , C07D211/84 , C07D223/06 , C07D233/28 , C07D233/30 , C07D233/32 , C07D233/36 , C07D233/40 , C07D233/42 , C07D233/66 , C07D233/70 , C07D233/84 , C07D239/06 , C07D239/10 , C07D239/20 , C07D239/22 , C07D239/36 , C07D239/47 , C07D239/54 , C07D241/06 , C07D241/08 , C07D241/18 , C07D243/04 , C07D253/06 , C07D263/16 , C07D263/20 , C07D263/22 , C07D263/34 , C07D265/04 , C07D267/04 , C07D277/12 , C07D277/32 , C07D277/34 , C07D279/06 , C07D281/02 , C07D401/12 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/12
CPC classification number: C07D207/27 , C07D207/404 , C07D207/408 , C07D223/10 , C07D233/32 , C07D233/42 , C07D239/10 , C07D239/22 , C07D241/08 , C07D241/18 , C07D253/06 , C07D263/22 , C07D307/20 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D409/14 , C07D417/12
Abstract: PROBLEM TO BE SOLVED: To provide novel compounds and a composition and method for inhibiting retroviral proteases and in particular for inhibiting human immunodeficiency virus (HIV) protease, a composition and method for inhibiting a retroviral infection and in particular an HIV infection, processes for making the compounds and synthetic intermediates employed in the processes.SOLUTION: There are provided a compound of formula (I) as HIV protease inhibitor or its pharmaceutically acceptable salt, ester or prodrug, and intermediates thereof.
Abstract translation: 待解决的问题:为了提供新的化合物和用于抑制逆转录病毒蛋白酶,特别是用于抑制人类免疫缺陷病毒(HIV)蛋白酶的组合物和方法,用于抑制逆转录病毒感染,特别是HIV感染的组合物和方法, 用于制备在该方法中使用的化合物和合成中间体的方法。 提供式(I)化合物作为HIV蛋白酶抑制剂或其药学上可接受的盐,酯或前药及其中间体。 版权所有(C)2013,JPO&INPIT
-
公开(公告)号:JPH1087639A
公开(公告)日:1998-04-07
申请号:JP13236996
申请日:1996-05-27
Applicant: ABBOTT LAB
Inventor: KEMPF DALE J , NORBECK DANIEL W , SHAM HING L , CHEN ZUAO , THOMAS J SOOUIN , DANIEL S RENO , HAIGHT ANTHONY R , ARTHUR J COOPER
IPC: C07D275/02 , A61K31/395 , A61K31/415 , A61K31/4164 , A61K31/42 , A61K31/421 , A61K31/422 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/535 , A61K31/5375 , A61K31/5377 , A61K31/54 , A61K38/00 , A61K45/06 , A61P31/12 , A61P31/18 , A61P35/00 , A61P35/02 , A61P37/04 , A61P43/00 , C07C33/46 , C07C43/164 , C07C43/174 , C07C43/205 , C07C43/215 , C07C43/23 , C07C43/30 , C07C43/315 , C07C45/00 , C07C45/29 , C07C45/56 , C07C45/62 , C07C45/67 , C07C45/74 , C07C53/134 , C07C69/34 , C07C69/65 , C07C69/732 , C07C211/27 , C07C215/18 , C07C215/20 , C07C215/28 , C07C229/08 , C07C229/26 , C07C229/34 , C07C233/36 , C07C233/40 , C07C235/10 , C07C235/12 , C07C235/34 , C07C235/78 , C07C237/10 , C07C237/20 , C07C237/22 , C07C239/10 , C07C239/18 , C07C239/20 , C07C247/10 , C07C251/40 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/16 , C07C275/24 , C07C311/03 , C07C311/13 , C07C311/18 , C07C317/10 , C07C317/28 , C07C317/44 , C07C323/12 , C07C323/25 , C07C381/00 , C07D20060101 , C07D213/26 , C07D213/30 , C07D213/34 , C07D213/40 , C07D213/54 , C07D213/56 , C07D213/61 , C07D213/75 , C07D233/54 , C07D233/84 , C07D235/10 , C07D235/14 , C07D235/16 , C07D239/26 , C07D241/12 , C07D261/06 , C07D261/08 , C07D263/24 , C07D263/30 , C07D263/32 , C07D263/48 , C07D265/30 , C07D277/22 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/32 , C07D277/34 , C07D277/36 , C07D277/40 , C07D277/42 , C07D277/56 , C07D295/13 , C07D295/205 , C07D295/215 , C07D303/36 , C07D307/42 , C07D333/16 , C07D401/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D521/00 , C07F5/02 , C07F5/04 , C07K5/06 , C07K5/065
Abstract: PROBLEM TO BE SOLVED: To obtain the subject new compound used as an intermediate for synthesizing compounds inhibiting the proteases of retroviruses, especially the protease of human immunodeficiency virus causing human acquired immunodeficiency syndrome and for synthesizing medicines for treating the disease. SOLUTION: Compounds of formulas I and II (R is H, a lower alkyl), e.g. N-(((benzyl)oxy)carbonyl)-L-phenylalaninal. The compound of formula I, etc., is obtained e.g. by binding a protected O-aminoaldehyde of formula III to a compound of the formula VCl3 (tetrahydrofuran)3 and Zn to produce a diol mixture, isolating a compound of formula IV, and subsequently hydrolyzing the isolated compound of formula IV with Ba(OH)2 to produce an aminodiol of formula V.
-
公开(公告)号:JP2010215650A
公开(公告)日:2010-09-30
申请号:JP2010126002
申请日:2010-06-01
Applicant: Abbott Lab , アボツト・ラボラトリーズ
Inventor: KEMPF DALE J , NORBECK DANIEL W , SHAM HING L , CHEN ZUAO , THOMAS J SOOUIN , DANIEL S RENO , HAIGHT ANTHONY R , ARTHUR J COOPER
IPC: A61K31/422 , C07D275/02 , A61K31/395 , A61K31/415 , A61K31/4164 , A61K31/42 , A61K31/421 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/535 , A61K31/5375 , A61K31/5377 , A61K31/54 , A61K38/00 , A61K45/00 , A61K45/06 , A61P31/12 , A61P31/18 , A61P35/00 , A61P35/02 , A61P37/04 , A61P43/00 , C07C33/46 , C07C43/164 , C07C43/174 , C07C43/205 , C07C43/215 , C07C43/23 , C07C43/30 , C07C43/315 , C07C45/00 , C07C45/29 , C07C45/56 , C07C45/62 , C07C45/67 , C07C45/74 , C07C53/134 , C07C69/34 , C07C69/65 , C07C69/732 , C07C211/27 , C07C215/18 , C07C215/20 , C07C215/28 , C07C229/08 , C07C229/26 , C07C229/34 , C07C233/36 , C07C233/40 , C07C235/10 , C07C235/12 , C07C235/34 , C07C235/78 , C07C237/10 , C07C237/20 , C07C237/22 , C07C239/10 , C07C239/18 , C07C239/20 , C07C247/10 , C07C251/40 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/16 , C07C275/24 , C07C311/03 , C07C311/13 , C07C311/18 , C07C317/10 , C07C317/28 , C07C317/44 , C07C323/12 , C07C323/25 , C07C381/00 , C07D20060101 , C07D213/26 , C07D213/30 , C07D213/34 , C07D213/40 , C07D213/54 , C07D213/56 , C07D213/61 , C07D213/75 , C07D233/54 , C07D233/84 , C07D235/10 , C07D235/14 , C07D235/16 , C07D239/26 , C07D241/12 , C07D261/06 , C07D261/08 , C07D263/24 , C07D263/30 , C07D263/32 , C07D263/48 , C07D265/30 , C07D277/20 , C07D277/22 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/32 , C07D277/34 , C07D277/36 , C07D277/40 , C07D277/42 , C07D277/56 , C07D295/13 , C07D295/205 , C07D295/215 , C07D303/36 , C07D307/42 , C07D333/16 , C07D401/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D521/00 , C07F5/02 , C07F5/04 , C07K5/06 , C07K5/065
CPC classification number: C07D413/12 , A61K31/425 , A61K31/427 , A61K31/70 , A61K38/00 , A61K45/06 , C07C33/46 , C07C43/164 , C07C43/1742 , C07C43/2055 , C07C43/215 , C07C43/23 , C07C43/30 , C07C43/315 , C07C45/004 , C07C45/29 , C07C45/567 , C07C45/62 , C07C45/673 , C07C45/74 , C07C53/134 , C07C69/34 , C07C69/65 , C07C69/732 , C07C211/27 , C07C215/18 , C07C215/20 , C07C215/28 , C07C229/08 , C07C229/26 , C07C229/34 , C07C233/36 , C07C233/40 , C07C235/10 , C07C235/12 , C07C235/34 , C07C235/78 , C07C237/10 , C07C237/20 , C07C237/22 , C07C239/10 , C07C239/18 , C07C239/20 , C07C247/10 , C07C251/40 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/16 , C07C275/24 , C07C311/03 , C07C311/13 , C07C311/18 , C07C317/10 , C07C317/28 , C07C317/44 , C07C323/12 , C07C323/25 , C07C381/00 , C07D213/26 , C07D213/30 , C07D213/34 , C07D213/40 , C07D213/54 , C07D213/56 , C07D213/61 , C07D213/75 , C07D231/12 , C07D233/56 , C07D233/64 , C07D233/84 , C07D235/14 , C07D235/16 , C07D239/26 , C07D241/12 , C07D249/08 , C07D261/08 , C07D263/32 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/34 , C07D277/36 , C07D277/40 , C07D277/42 , C07D277/56 , C07D295/13 , C07D295/205 , C07D295/215 , C07D303/36 , C07D307/42 , C07D333/16 , C07D401/12 , C07D417/12 , C07K5/06026 , C07K5/06078 , A61K31/00 , A61K2300/00 , C07C49/233 , C07C49/255 , C07C49/215 , C07C49/245 , C07C49/235 , C07C49/223
Abstract: PROBLEM TO BE SOLVED: To provide new compounds and compositions inhibiting retroviral protease especially human immunodeficiency virus (HIV) protease, and to provide compositions treating retroviral infection especially HIV infection.
SOLUTION: There are provided combinations of a compound of formula A1 or a pharmaceutically permissible salt thereof with another kind of retroviral protease inhibitors. Such retroviral protease inhibitor is preferably a HIV protease inhibitor especially one selected from Ro31-8959, SC-52151, KNI-227 and KNI-272.
COPYRIGHT: (C)2010,JPO&INPITAbstract translation: 要解决的问题:提供抑制逆转录病毒蛋白酶,特别是人类免疫缺陷病毒(HIV)蛋白酶的新化合物和组合物,并提供治疗逆转录病毒感染,特别是HIV感染的组合物。 解决方案:提供式A1化合物或其药学上允许的盐与另一种逆转录病毒蛋白酶抑制剂的组合。 这种逆转录病毒蛋白酶抑制剂优选为HIV蛋白酶抑制剂,特别是选自Ro31-8959,SC-52151,KNI-227和KNI-272中的一种。 版权所有(C)2010,JPO&INPIT
-
公开(公告)号:JP2002322159A
公开(公告)日:2002-11-08
申请号:JP2002054592
申请日:2002-02-28
Applicant: ABBOTT LAB
Inventor: KEMPF DALE J , NORBECK DANIEL W , SHAM HING L , CHEN ZUAO , THOMAS J SOOUIN , DANIEL S RENO , HAIGHT ANTHONY R , ARTHUR J COOPER
IPC: C07D275/02 , A61K31/395 , A61K31/415 , A61K31/4164 , A61K31/42 , A61K31/421 , A61K31/422 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/535 , A61K31/5375 , A61K31/5377 , A61K31/54 , A61K38/00 , A61K45/06 , A61P31/12 , A61P31/18 , A61P35/00 , A61P35/02 , A61P37/04 , A61P43/00 , C07C33/46 , C07C43/164 , C07C43/174 , C07C43/205 , C07C43/215 , C07C43/23 , C07C43/30 , C07C43/315 , C07C45/00 , C07C45/29 , C07C45/56 , C07C45/62 , C07C45/67 , C07C45/74 , C07C53/134 , C07C69/34 , C07C69/65 , C07C69/732 , C07C211/27 , C07C215/18 , C07C215/20 , C07C215/28 , C07C229/08 , C07C229/26 , C07C229/34 , C07C233/36 , C07C233/40 , C07C235/10 , C07C235/12 , C07C235/34 , C07C235/78 , C07C237/10 , C07C237/20 , C07C237/22 , C07C239/10 , C07C239/18 , C07C239/20 , C07C247/10 , C07C251/40 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/16 , C07C275/24 , C07C311/03 , C07C311/13 , C07C311/18 , C07C317/10 , C07C317/28 , C07C317/44 , C07C323/12 , C07C323/25 , C07C381/00 , C07D20060101 , C07D213/26 , C07D213/30 , C07D213/34 , C07D213/40 , C07D213/54 , C07D213/56 , C07D213/61 , C07D213/75 , C07D233/54 , C07D233/84 , C07D235/10 , C07D235/14 , C07D235/16 , C07D239/26 , C07D241/12 , C07D261/06 , C07D261/08 , C07D263/24 , C07D263/30 , C07D263/32 , C07D263/48 , C07D265/30 , C07D277/22 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/32 , C07D277/34 , C07D277/36 , C07D277/40 , C07D277/42 , C07D277/56 , C07D295/13 , C07D295/205 , C07D295/215 , C07D303/36 , C07D307/42 , C07D333/16 , C07D401/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D521/00 , C07F5/02 , C07F5/04 , C07K5/06 , C07K5/065
Abstract: PROBLEM TO BE SOLVED: To provide a new compound that inhibits retrovirus proteases, especially proteases of human immunodeficiency virus(HIV), a composition for treating retrovirus infection, especially for treating HIV infection, a production method of the compound, and a synthetic intermediate used in the method. SOLUTION: A compound represented by formula (A) is provided [wherein, R1 , R2 , R3 and R6 are each H or a lower alkyl group; R4 and R4a are each a phenyl, thiazolyl, oxazolyl, isoxazolyl or isothiazolyl group; X and Y are each H or OH; Z is none or O]. For example, (2S, 3S, 5S)-5-(N-(N-((N-methyl- N-((2-cyclohexyl-4-thiazolyl)methyl)amino)carbonyl)valinyl)amino-2-(N- ((5- thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane is provided.
-
7.
公开(公告)号:JP2010270123A
公开(公告)日:2010-12-02
申请号:JP2010150808
申请日:2010-07-01
Applicant: Abbott Lab , アボット・ラボラトリーズAbbott Laboratories
Inventor: TIEN JIEN-HEH , MENZIA JEROME A , ARTHUR J COOPER
IPC: C07D277/28 , A61K31/427 , A61P31/18 , A61P43/00
CPC classification number: C07D277/28
Abstract: PROBLEM TO BE SOLVED: To provide a method for producing (2S, 3S, 5S)-5-(N-(N-((N-methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)-L-valinyl)amino)-2-(N-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane useful as an HIV protease inhibitor or an acid addition salt thereof. SOLUTION: The method for the preparation comprises converting a mixture anhydride derivative of N-((N-methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)-L-valine to an activated ester derivative of N-((N-methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)-L-valine and then reacting the activated ester with (2S, 3S, 5S)-5-amino-2-(N-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane. COPYRIGHT: (C)2011,JPO&INPIT
Abstract translation: 解决方案:提供(2S,3S,5S)-5-(N-(N - ((N-甲基-N - ((2-异丙基-4-噻唑基)甲基) 氨基)羰基)-L-缬氨酰基)氨基)-2-(N - ((5-噻唑基)甲氧基羰基)氨基)-1,6-二苯基-3-羟基己烷可用作HIV蛋白酶抑制剂或其酸加成盐。 解决方案:制备方法包括将N - ((N-甲基-N - ((2-异丙基-4-噻唑基)甲基)氨基)羰基)-L-缬氨酸的混合酸酐衍生物转化为活化的 N - ((N-甲基-N - ((2-异丙基-4-噻唑基)甲基)氨基)羰基)-L-缬氨酸的酯衍生物,然后使活化的酯与(2S,3S,5S)-5- 氨基-2-(N - ((5-噻唑基)甲氧基羰基)氨基)-1,6-二苯基-3-羟基己烷。 版权所有(C)2011,JPO&INPIT
-
公开(公告)号:JP2009035560A
公开(公告)日:2009-02-19
申请号:JP2008211071
申请日:2008-08-19
Applicant: Abbott Lab , アボット・ラボラトリーズAbbott Laboratories
Inventor: PATRICIA A OLIVER , ARTHUR J COOPER , LALLAMAN JOHN E , LANDGRIDGE DENTON C , TIEN JIEH-HEH J
IPC: C07D277/28 , C07D277/30
CPC classification number: C07D277/28
Abstract: PROBLEM TO BE SOLVED: To provide a new process for producing an N-((N-methyl-N-((2-isopropyl-4-thyazolyl)methyl)amino)carbonyl)-amino acid derivative.
SOLUTION: The process comprises a reaction of an N-phenoxycarbonyl-L-valine with an N-methyl-N-((2-isopropyl-4-thyazolyl)methyl)amine at room temperature in THF.
COPYRIGHT: (C)2009,JPO&INPITAbstract translation: 待解决的问题:提供制备N - ((N-甲基-N - ((2-异丙基-4-甲唑基)甲基)氨基)羰基) - 氨基酸衍生物的新方法。 解决方案:该方法包括在室温下在THF中N-苯氧基羰基-L-缬氨酸与N-甲基-N - ((2-异丙基-4-甲唑基)甲基)胺的反应。 版权所有(C)2009,JPO&INPIT
-
公开(公告)号:JP2001058979A
公开(公告)日:2001-03-06
申请号:JP2000190510
申请日:2000-06-26
Applicant: ABBOTT LAB
Inventor: SHAM HING LEUNG , NORBECK DANIEL W , CHEN XIAOQI , BETEBENNER DAVID A , DALE J KEMP , THOMAS R HERIN , GONDEI N KUMAA , STEVEN L CONDON , ARTHUR J COOPER , DANIEL A DICKMAN , STEVEN M HANNIKKU , LAWRENCE KORATSUEKOUSUKII , PATRICIA A OLIVER , DANIEL J PRATA , PETER J STENGEL , ERIK J SUTOONAA , JII-HAA J TEIEN , JII-HOWA RIU , KETAN M PATEL
IPC: C07D253/00 , A61K31/00 , A61K31/40 , A61K31/4015 , A61K31/41 , A61K31/415 , A61K31/4164 , A61K31/4166 , A61K31/4184 , A61K31/42 , A61K31/421 , A61K31/425 , A61K31/427 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/4439 , A61K31/47 , A61K31/495 , A61K31/496 , A61K31/4965 , A61K31/505 , A61K31/513 , A61K31/53 , A61K31/55 , A61K38/05 , A61K45/00 , A61P31/18 , A61P43/00 , C07C231/12 , C07C235/20 , C07C273/18 , C07C275/16 , C07D20060101 , C07D207/22 , C07D207/26 , C07D207/27 , C07D207/273 , C07D207/34 , C07D207/40 , C07D207/404 , C07D207/408 , C07D207/416 , C07D211/72 , C07D211/84 , C07D223/06 , C07D233/28 , C07D233/30 , C07D233/32 , C07D233/36 , C07D233/40 , C07D233/42 , C07D233/66 , C07D239/06 , C07D239/10 , C07D239/20 , C07D239/22 , C07D241/06 , C07D241/08 , C07D241/18 , C07D243/04 , C07D253/06 , C07D263/16 , C07D263/20 , C07D263/22 , C07D263/34 , C07D265/04 , C07D267/04 , C07D277/12 , C07D277/32 , C07D277/34 , C07D279/06 , C07D281/02 , C07D401/12 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/12
Abstract: PROBLEM TO BE SOLVED: To obtain a new compound having retrovirus protease inhibiting activities, and useful for treatment of disease caused by retrovirus. e.g. Acquired Immune Deficiency Syndrome(AIDS) and human acute cellular leukemia. SOLUTION: This new compound is represented by formula I [R1 and R2 are each a lower alkyl, a cycloalkyl or an arylalkyl; R3 is a lower alkyl, a hydroxyalkyl or the like; R4 is an aryl or the like; R5 is a group of formula II (n is 1-3; X is O, S or the like; Y is CH2 or the like) or the like; L1 is O, S or the like], and exemplified by (2S,3S,5S)-2-(2,6-dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-(1-tetrahydropyrimid-2-onyl)-3-methylbutanoyl]am ino-1,6- diphenylhexane. The compound of formula I is obtained by reacting a compound of formula III with a compound of formula IV in the presence of a diimide to provide a compound of formula V, deprotecting the N, and reacting the deprotected N with a carboxylic acid.
-
公开(公告)号:DK0854872T3
公开(公告)日:2002-07-29
申请号:DK97923661
申请日:1997-05-19
Applicant: ABBOTT LAB
Inventor: PATRICIA A OLIVER , ARTHUR J COOPER , JOHN E LALLAMAN , DENTON C LANDGRIDGE , JIEH-HEH J TIEN
IPC: C07D277/28 , C07D277/30
Abstract: A process is disclosed for the preparation of N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)-amino acid derivatives.
-
-
-
-
-
-
-
-
-